Market Closed

MIST
Milestone Pharmaceuticals
$ 0.5200
-20.63%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Milestone Pharmaceuticals News

Latest Milestone Pharmaceuticals Stock News & MIST Headlines

Milestone Pharmaceuticals Inc. (MIST) Q3 2026 Earnings Call Transcript
2 days ago | seekingalpha.com
Milestone Pharmaceuticals Q3 Earnings Call Highlights
2 days ago | marketbeat.com
Milestone Pharmaceuticals (MIST) Reports Q3 Loss, Beats Revenue Estimates
2 days ago | zacks.com
Milestone Pharmaceuticals Reports Third Quarter 2026 Financial Results and Announces Cost-Efficiency Measures Designed to Extend Cash Runway Through AFib-RVR Phase 3 Data
2 days ago | globenewswire.com
Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
12 days ago | globenewswire.com
New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation
13 days ago | globenewswire.com
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences
a month ago | globenewswire.com
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
2 months ago | globenewswire.com
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Given Average Rating of “Moderate Buy” by Brokerages
2 months ago | defenseworld.net
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
2 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

MIST
Milestone Pharmaceuticals
$ 0.5200
-20.63%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago